Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 84701-84750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05042102
Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)
PHASE2Recruiting
160 participants
Started: Aug 8, 2022 · Completed: May 31, 2027
1 condition3 sponsors1 location
NCT05061108
Linkage, Empowerment, and Access to Prevent Hypertension
NAActive, not recruiting
330 participants
Started: Aug 8, 2022 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT05236036
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PHASE1Recruiting
60 participants
Started: Aug 8, 2022 · Completed: Jan 3, 2029
5 conditions2 sponsors1 location
NCT04858776
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
PHASE2Recruiting
60 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT05527860
Evolution of the State of Health of Patients Undergoing Surgery for Osteoarticular Surgery
N/ARecruiting
4,000 participants
Started: Aug 8, 2022 · Completed: Jan 8, 2024
1 condition1 sponsor1 location
NCT05510362
Management and Short Term Outcome of Traumatic Wounds in the Emergency Department
N/ARecruiting
3,000 participants
Started: Aug 8, 2022 · Completed: Oct 10, 2025
1 condition1 sponsor1 location
NCT04651777
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
PHASE3Active, not recruiting
31 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05471011
COVID-19 Outcome Prediction Algorithm
N/ARecruiting
600 participants
Started: Aug 8, 2022 · Completed: May 31, 2026
5 conditions7 sponsors7 locations
NCT05170126
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
N/ARecruiting
1,182 participants
Started: Aug 8, 2022 · Completed: Jun 30, 2032
1 condition1 sponsor3 locations
NCT05440760
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
NARecruiting
20 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05333471
Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
PHASE1/PHASE2Recruiting
20 participants
Started: Aug 8, 2022 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05121324
Pediatric Dose Optimization for Seizures in Emergency Medical Services
PHASE3Recruiting
6,700 participants
Started: Aug 8, 2022 · Completed: Sep 30, 2026
1 condition4 sponsors20 locations
NCT05226247
Systolic Function and Weaning-induced Pulmonary Edema (SystoWean Study)
NARecruiting
250 participants
Started: Aug 8, 2022 · Completed: Sep 1, 2024
2 conditions1 sponsor3 locations
NCT06592365
Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation
NARecruiting
84 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor3 locations
NCT05680025
Effect of a Physical Exercise Intervention Based on the Transtheoretical Model on Blood Pressure
NAEnrolling by invitation
442 participants
Started: Aug 8, 2022 · Completed: Aug 30, 2024
1 condition1 sponsor1 location
NCT05472857
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
PHASE1Recruiting
30 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT05728359
Genomic Determinants of Outcome in Cardiogenic Shock
N/ARecruiting
300 participants
Started: Aug 8, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT04989790
"Clinical Effectiveness of the PICU Up! Multifaceted Early Mobility Intervention for Critically Ill Children"
NARecruiting
1,440 participants
Started: Aug 8, 2022 · Completed: Mar 31, 2026
4 conditions2 sponsors11 locations
NCT05495737
Meaning-Centered Psychotherapy at Home
N/AActive, not recruiting
81 participants
Started: Aug 8, 2022 · Completed: Aug 8, 2026
2 conditions1 sponsor2 locations
NCT06065813
Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer
PHASE2Recruiting
20 participants
Started: Aug 8, 2022 · Completed: May 30, 2026
4 conditions2 sponsors1 location
NCT05125211
Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects
PHASE1Active, not recruiting
91 participants
Started: Aug 8, 2022 · Completed: May 29, 2026
1 condition1 sponsor1 location
NCT05254171
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
PHASE2/PHASE3Recruiting
600 participants
Started: Aug 8, 2022 · Completed: Jan 1, 2027
3 conditions1 sponsor93 locations
NCT05839938
The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis
NAEnrolling by invitation
150 participants
Started: Aug 8, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05413655
A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
PHASE2Recruiting
120 participants
Started: Aug 8, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT04558541
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
NARecruiting
400 participants
Started: Aug 7, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors2 locations
NCT05466786
Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
N/ARecruiting
255 participants
Started: Aug 7, 2022 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT05599360
Vyxeos for Induction of Low- or Intermediate-risk.
PHASE2Active, not recruiting
20 participants
Started: Aug 7, 2022 · Completed: Sep 7, 2028
1 condition1 sponsor1 location
NCT05406349
Neural Mechanisms of Spatial Representations Beyond the Self
NARecruiting
60 participants
Started: Aug 6, 2022 · Completed: Apr 30, 2027
1 condition4 sponsors1 location
NCT05484024
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
PHASE2/PHASE3Not yet recruiting
588 participants
Started: Aug 6, 2022 · Completed: Jul 31, 2030
2 conditions1 sponsor2 locations
NCT05445310
Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer
PHASE2Recruiting
114 participants
Started: Aug 6, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05434130
Modulating Exercise Dosage to Improve Concussion Recovery
PHASE2Recruiting
216 participants
Started: Aug 5, 2022 · Completed: Feb 1, 2027
5 conditions4 sponsors3 locations
NCT05532930
An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)
N/ARecruiting
40 participants
Started: Aug 5, 2022 · Completed: Mar 1, 2026
1 condition3 sponsors1 location
NCT05463887
Personalized Disease Prevention
NAActive, not recruiting
660 participants
Started: Aug 5, 2022 · Completed: Jan 31, 2026
4 conditions2 sponsors1 location
NCT04763915
Improving Care After Inherited Cancer Testing
NAActive, not recruiting
720 participants
Started: Aug 5, 2022 · Completed: Dec 31, 2028
5 conditions3 sponsors1 location
NCT05476640
Newborn Sequencing Screening in China
N/ANot yet recruiting
10,000 participants
Started: Aug 5, 2022 · Completed: Dec 31, 2025
1 condition7 sponsors0 locations
NCT05063201
Cariprazine for Comorbid Cocaine and Opioid Use Disorder
PHASE2Recruiting
48 participants
Started: Aug 5, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05376267
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
NARecruiting
900 participants
Started: Aug 5, 2022 · Completed: Mar 31, 2028
3 conditions3 sponsors54 locations
NCT05074940
Amivantamab in Adenoid Cystic Carcinoma
PHASE2Active, not recruiting
18 participants
Started: Aug 5, 2022 · Completed: Aug 5, 2028
1 condition1 sponsor5 locations
NCT05388669
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
PHASE3Active, not recruiting
418 participants
Started: Aug 5, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor187 locations
NCT04833816
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
PHASE3Recruiting
140 participants
Started: Aug 5, 2022 · Completed: Jan 3, 2026
1 condition1 sponsor1 location
NCT05328505
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
NARecruiting
80 participants
Started: Aug 5, 2022 · Completed: Aug 31, 2030
1 condition1 sponsor1 location
NCT04817462
Liver Biopsy In Haemophilia Gene Therapy
NARecruiting
10 participants
Started: Aug 5, 2022 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT05982691
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
N/ARecruiting
400 participants
Started: Aug 5, 2022 · Completed: Dec 31, 2032
3 conditions1 sponsor1 location
NCT05306496
Laparoscopic Inguinal and Femoral heRniA rePaIr Using Pre-shapeD 4DMESH® (4DLap)
NARecruiting
200 participants
Started: Aug 4, 2022 · Completed: Sep 30, 2029
2 conditions1 sponsor9 locations
NCT05262036
The Effects of a Longevity Supplement on Aging and Photoaging
NAActive, not recruiting
38 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2023
1 condition2 sponsors1 location
NCT05517044
The Pre-acclimatization Augmented Extreme Altitude Expedition
NAActive, not recruiting
30 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05245331
Transanal Irrigation for Low Anterior Resection Syndrome.
NAActive, not recruiting
20 participants
Started: Aug 4, 2022 · Completed: Nov 30, 2025
1 condition3 sponsors2 locations
NCT05426083
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
N/ARecruiting
200 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05563623
The Beijing Angle Closure Progression Study
N/ARecruiting
825 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06809699
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1Recruiting
29 participants
Started: Aug 4, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor1 location